About Conjunctivitis Conjunctivitis, also called pink eye or Madras eye, is an infection in or inflammation of the conjunctiva. It affects either one or both a persons eyes and can be the result of an allergy, bacteria, or a virus. Allergens such as smoke, pollen, dust mites, eye drops, cosmetics, and perfumes can lead to conjunctivitis. It is usually associated with redness of the eye along with the release of mucoid discharges. Although the condition usually heals without medication, antibiotics are commonly used for treatment to avoid complications due to irritation of the eye. Technavios analysts forecast the global conjunctivitis medication market to grow at a CAGR of 1.94% during the period 2015-2019. Covered in this report The report covers the present scenario and the growth prospects of the global conjunctivitis medication market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of various prescription medication along with the over-the-counter (OTC) medication used to treat bacterial, viral, and allergic conjunctivitis. The market is divided into the following segments... Research Beam Model: Research Beam Product ID: 386086 2500 USD New
Global Conjunctivitis Market 2015-2019
 

Global Conjunctivitis Market 2015-2019

Global Conjunctivitis Market 2015-2019

Category : Healthcare
Published On : January  2016
Pages : 72

request-discount


TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Conjunctivitis

Conjunctivitis, also called pink eye or Madras eye, is an infection in or inflammation of the conjunctiva. It affects either one or both a persons eyes and can be the result of an allergy, bacteria, or a virus. Allergens such as smoke, pollen, dust mites, eye drops, cosmetics, and perfumes can lead to conjunctivitis. It is usually associated with redness of the eye along with the release of mucoid discharges. Although the condition usually heals without medication, antibiotics are commonly used for treatment to avoid complications due to irritation of the eye.

Technavios analysts forecast the global conjunctivitis medication market to grow at a CAGR of 1.94% during the period 2015-2019.

Covered in this report 
The report covers the present scenario and the growth prospects of the global conjunctivitis medication market for 2015-2019. To calculate the market size, the report considers revenue generated from the sale of various prescription medication along with the over-the-counter (OTC) medication used to treat bacterial, viral, and allergic conjunctivitis.

The market is divided into the following segments based on geography: 
APAC
EMEA
Americas

Technavios report, Global Conjunctivitis Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key vendors 
Akorn
Alcon
Allergan
Bausch & Lomb 

Other prominent vendors 
Celsus Therapeutics
Eleven Biotherapeutics
Griffin Discoveries
InSite Vision
Merck
Nicox
NovaBay
Ocular Therapeutix
Santen Pharmaceutical
Shire (Foresight Biotherapeutics)
Starpharma
Sun Pharmaceutical

Market driver 
Increased exposure to chemicals and pollutants
For a full, detailed list, view our report 

Market challenge 
Patent expiry of medication
For a full, detailed list, view our report 

Market trend 
Strategic alliances and M&A
For a full, detailed list, view our report 

Key questions answered in this report 
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors? 

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

PART 01: Executive summary
Highlights

PART 02: Scope of the report
Market overview
Top-vendor offerings

PART 03: Market research methodology
Research methodology
Economic indicators

PART 04: Introduction
Key market highlights

PART 05: Overview: Conjunctivitis
Types of conjunctivitis
Signs and symptoms
Diagnosis

PART 06: Pipeline analysis
AC-170
AGN-229666
DEXTENZA
SUN-1334H
Auriclosene
EBI-005
FST-100
SPL7013
OPX-1
AzaSite Xtra (ISV-405)
GD134

PART 07: Market landscape
Market overview
Market size and forecast
Conjunctivitis medication market in the US
Bacterial conjunctivitis medication market in the US
Viral conjunctivitis medication market in the US
Allergic conjunctivitis medication market in the US
Five forces analysis

PART 08: Market segmentation based on condition type
Bacterial conjunctivitis medication
Viral conjunctivitis medication
Allergic conjunctivitis medication
Global bacterial conjunctivitis medication market
Global viral conjunctivitis medication market
Global allergic conjunctivitis medication market

PART 09: Geographical segmentation
Geographical segmentation of global conjunctivitis medication market
Conjunctivitis medication market in the Americas
Conjunctivitis medication market in EMEA
Conjunctivitis medication market in APAC

PART 10: Market drivers
Increased exposure to chemicals and pollutants
Rising awareness of condition
Exploring specific treatment for viral conjunctivitis
Tentative approval of pipeline candidates

PART 11: Impact of drivers

PART 12: Market challenges
Patent expiry of medication
Contentment with existing therapies
Adverse effects and limited efficacy of medication

PART 13: Impact of drivers and challenges

PART 14: Market trends
Strategic alliances and M&A
Use of combination therapies
Increased R&D

PART 15: Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 16: Key vendor analysis
Akorn
Alcon
Allergan
Bausch & Lomb

PART 17: Appendix
List of abbreviations

PART 18: Explore Technavio

List Of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Causes of conjunctivitis
Exhibit 03: Types of bacterial conjunctivitis
Exhibit 04: Types of viral conjunctivitis
Exhibit 05: Types of allergic conjunctivitis
Exhibit 06: Signs and symptoms of common forms of conjunctivitis
Exhibit 07: Medication used for treatment of conjunctivitis
Exhibit 08: Global conjunctivitis market: Pipeline portfolio
Exhibit 09: Global conjunctivitis market 2014-2019 ($ billions)
Exhibit 10: Conjunctivitis market in the US 2014-2019 ($ billions)
Exhibit 11: Percentage shares of conjunctivitis medication market in the US and outside the US
Exhibit 12: Segmentation of conjunctivitis medication market in US based on condition type 2014
Exhibit 13: Bacterial conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 14: Viral conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 15: Allergic conjunctivitis medication market in the US 2014-2019 ($ millions)
Exhibit 16: Conjunctivitis market in US: YoY growth and revenue based on condition type 2014-2019
Exhibit 17: Five forces analysis
Exhibit 18: Segmentation of global conjunctivitis medication market based on condition type
Exhibit 19: Segmentation of global conjunctivitis medication market based on condition type 2014
Exhibit 20: Global bacterial conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 21: Global viral conjunctivitis medication market 2014-2019 ($ millions)
Exhibit 22: Global allergic conjunctivitis medication market 2014-2019 ($ billions)
Exhibit 23: Global conjunctivitis medication market: YoY growth and revenue based on condition type 2014-2019
Exhibit 24: Geographical segmentation of global conjunctivitis medication market 2014
Exhibit 25: Conjunctivitis medication market in the Americas 2014-2019 ($ billions)
Exhibit 26: Conjunctivitis medication market in EMEA 2014-2019 ($ millions)
Exhibit 27: Conjunctivitis medication market in APAC 2014-2019 ($ millions)
Exhibit 28: YoY growth and revenue of global conjunctivitis medication market by region 2014-2019
Exhibit 29: Impact of drivers
Exhibit 30: Impact of drivers and challenges
Exhibit 31: YoY growth and revenue generated from sales of ophthalmic therapeutics 2011-2013 ($ millions)
Exhibit 32: Akorn: Key takeaways
Exhibit 33: YoY growth and revenue generated from sales of ophthalmic products 2011-2014 ($ billions)
Exhibit 34: Percentage share of divisions of Alcon based on revenue 2014
Exhibit 35: Alcon: Key takeaways
Exhibit 36: Allergan: Key takeaways
Exhibit 37: Allergan: Business segmentation 2014 by revenue
Exhibit 38: Allergan: Business segmentation by revenue 2013 and 2014 ($ billions)
Exhibit 39: Allergan: Geographical segmentation by revenue 2014
Exhibit 40: Bausch & Lomb: Product categories

Enquiry Before Buy